Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Rivaroxaban market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Rivaroxaban market. Detailed analysis of key players, along with key growth strategies adopted by Rivaroxaban industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bayer
J&J
By Type:
10 mg
15 mg
20 mg
By End-User:
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Rivaroxaban Market
-
1.3 Market Segment by Type
-
1.3.1 China Rivaroxaban Market Size and Growth Rate of 10 mg from 2016 to 2027
-
1.3.2 China Rivaroxaban Market Size and Growth Rate of 15 mg from 2016 to 2027
-
1.3.3 China Rivaroxaban Market Size and Growth Rate of 20 mg from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Rivaroxaban Market Size and Growth Rate of Acute Coronary Syndrome (ACS) from 2016 to 2027
-
1.4.2 China Rivaroxaban Market Size and Growth Rate of Venous Thromboembolism (VTE) from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Rivaroxaban Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Rivaroxaban by Major Types
-
3.4.1 Market Size and Growth Rate of 10 mg
-
3.4.2 Market Size and Growth Rate of 15 mg
-
3.4.3 Market Size and Growth Rate of 20 mg
4 Segmentation of Rivaroxaban Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Rivaroxaban by Major End-Users
-
4.4.1 Market Size and Growth Rate of Rivaroxaban in Acute Coronary Syndrome (ACS)
-
4.4.2 Market Size and Growth Rate of Rivaroxaban in Venous Thromboembolism (VTE)
5 Market Analysis by Regions
-
5.1 China Rivaroxaban Production Analysis by Regions
-
5.2 China Rivaroxaban Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Rivaroxaban Landscape Analysis
-
6.1 North China Rivaroxaban Landscape Analysis by Major Types
-
6.2 North China Rivaroxaban Landscape Analysis by Major End-Users
7 Central China Rivaroxaban Landscape Analysis
-
7.1 Central China Rivaroxaban Landscape Analysis by Major Types
-
7.2 Central China Rivaroxaban Landscape Analysis by Major End-Users
8 South China Rivaroxaban Landscape Analysis
-
8.1 South China Rivaroxaban Landscape Analysis by Major Types
-
8.2 South China Rivaroxaban Landscape Analysis by Major End-Users
9 East China Rivaroxaban Landscape Analysis
-
9.1 East China Rivaroxaban Landscape Analysis by Major Types
-
9.2 East China Rivaroxaban Landscape Analysis by Major End-Users
10 Northeast China Rivaroxaban Landscape Analysis
-
10.1 Northeast China Rivaroxaban Landscape Analysis by Major Types
-
10.2 Northeast China Rivaroxaban Landscape Analysis by Major End-Users
11 Southwest China Rivaroxaban Landscape Analysis
-
11.1 Southwest China Rivaroxaban Landscape Analysis by Major Types
-
11.2 Southwest China Rivaroxaban Landscape Analysis by Major End-Users
12 Northwest China Rivaroxaban Landscape Analysis
-
12.1 Northwest China Rivaroxaban Landscape Analysis by Major Types
-
12.2 Northwest China Rivaroxaban Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bayer
-
13.1.1 Bayer Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 J&J
-
13.2.1 J&J Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Rivaroxaban Market Size and Growth Rate of 10 mg from 2016 to 2027
-
Figure China Rivaroxaban Market Size and Growth Rate of 15 mg from 2016 to 2027
-
Figure China Rivaroxaban Market Size and Growth Rate of 20 mg from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Rivaroxaban Market Size and Growth Rate of Acute Coronary Syndrome (ACS) from 2016 to 2027
-
Figure China Rivaroxaban Market Size and Growth Rate of Venous Thromboembolism (VTE) from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Rivaroxaban Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Rivaroxaban Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Rivaroxaban
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Rivaroxaban by Different Types from 2016 to 2027
-
Table Consumption Share of Rivaroxaban by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 10 mg
-
Figure Market Size and Growth Rate of 15 mg
-
Figure Market Size and Growth Rate of 20 mg
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Rivaroxaban by Different End-Users from 2016 to 2027
-
Table Consumption Share of Rivaroxaban by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Acute Coronary Syndrome (ACS)
-
Figure Market Size and Growth Rate of Venous Thromboembolism (VTE)
-
Table China Rivaroxaban Production by Regions
-
Table China Rivaroxaban Production Share by Regions
-
Figure China Rivaroxaban Production Share by Regions in 2016
-
Figure China Rivaroxaban Production Share by Regions in 2021
-
Figure China Rivaroxaban Production Share by Regions in 2027
-
Table China Rivaroxaban Consumption by Regions
-
Table China Rivaroxaban Consumption Share by Regions
-
Figure China Rivaroxaban Consumption Share by Regions in 2016
-
Figure China Rivaroxaban Consumption Share by Regions in 2021
-
Figure China Rivaroxaban Consumption Share by Regions in 2027
-
Table North China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table North China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure North China Rivaroxaban Consumption Share by Types in 2016
-
Figure North China Rivaroxaban Consumption Share by Types in 2021
-
Figure North China Rivaroxaban Consumption Share by Types in 2027
-
Table North China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table North China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure North China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure North China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure North China Rivaroxaban Consumption Share by End-Users in 2027
-
Table Central China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table Central China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure Central China Rivaroxaban Consumption Share by Types in 2016
-
Figure Central China Rivaroxaban Consumption Share by Types in 2021
-
Figure Central China Rivaroxaban Consumption Share by Types in 2027
-
Table Central China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table Central China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure Central China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure Central China Rivaroxaban Consumption Share by End-Users in 2027
-
Table South China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table South China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure South China Rivaroxaban Consumption Share by Types in 2016
-
Figure South China Rivaroxaban Consumption Share by Types in 2021
-
Figure South China Rivaroxaban Consumption Share by Types in 2027
-
Table South China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table South China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure South China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure South China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure South China Rivaroxaban Consumption Share by End-Users in 2027
-
Table East China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table East China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure East China Rivaroxaban Consumption Share by Types in 2016
-
Figure East China Rivaroxaban Consumption Share by Types in 2021
-
Figure East China Rivaroxaban Consumption Share by Types in 2027
-
Table East China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table East China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure East China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure East China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure East China Rivaroxaban Consumption Share by End-Users in 2027
-
Table Northeast China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table Northeast China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Rivaroxaban Consumption Share by Types in 2016
-
Figure Northeast China Rivaroxaban Consumption Share by Types in 2021
-
Figure Northeast China Rivaroxaban Consumption Share by Types in 2027
-
Table Northeast China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table Northeast China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure Northeast China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure Northeast China Rivaroxaban Consumption Share by End-Users in 2027
-
Table Southwest China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table Southwest China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Rivaroxaban Consumption Share by Types in 2016
-
Figure Southwest China Rivaroxaban Consumption Share by Types in 2021
-
Figure Southwest China Rivaroxaban Consumption Share by Types in 2027
-
Table Southwest China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table Southwest China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure Southwest China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure Southwest China Rivaroxaban Consumption Share by End-Users in 2027
-
Table Northwest China Rivaroxaban Consumption by Types from 2016 to 2027
-
Table Northwest China Rivaroxaban Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Rivaroxaban Consumption Share by Types in 2016
-
Figure Northwest China Rivaroxaban Consumption Share by Types in 2021
-
Figure Northwest China Rivaroxaban Consumption Share by Types in 2027
-
Table Northwest China Rivaroxaban Consumption by End-Users from 2016 to 2027
-
Table Northwest China Rivaroxaban Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Rivaroxaban Consumption Share by End-Users in 2016
-
Figure Northwest China Rivaroxaban Consumption Share by End-Users in 2021
-
Figure Northwest China Rivaroxaban Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of J&J
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of J&J
-
Figure Sales and Growth Rate Analysis of J&J
-
Figure Revenue and Market Share Analysis of J&J
-
Table Product and Service Introduction of J&J
-
